Find a Provider

Beth-Karlan Photo

Specialty:: Obstetrics and Gynecology, Gynecological Oncology
Department Affiliation:: Obstetrics and Gynecology
Hospital Affiliation:: Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License:: G57519
Phone:: 310-205-0771
Health Plans:: Accepted Plans

About Me: Link to Dr. Karlan's complete CV >
Specialties include cancer genetics, hereditary breast/ovarian cancer, ovarian neoplasms, reproductive genetics, ovarian cancer, uterine cancer, clinical research, healthcare quality, biomedical research, adjuvant chemotherapy.
Links: uclahealth.org/community-cancercare
uclahealth.org/community-cancercare/beverly-hills

Primary Office: Beverly Hills - Cancer Care (Gynecologic Oncology)
Primary Address: 120 S. Spalding Drive
Suite 401
Beverly Hills, California 90212
: Get Directions
: View Map
Phone: 310-205-0771
Fax: 310-205-0801

Medical Board Certifications: Obstetrics and Gynecology, American Board of Obstetrics and Gynecology, 1990
Certification 2: Gynecologic Oncology, American Board of Obstetrics and Gynecology, 1991
Fellowship: Gynecologic Oncology, UCLA School of Medicine, 1987-1989
Residency: Obstetrics & Gynecology, Yale-New Haven Hospital - Internship/Residency Verification, 1982-1986
Degree: Harvard Medical School, MD, 1982

Publications

Kotsopoulos J, Lubinski J, Lynch HT, Tung N, Armel S, Senter, Karlan B, Narod SA, Hereditary Breast Cancer Clinical Study Group: Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2019 Feb 12. Doi:10.11007/s10549-019-05162-7. PMID: 30756284
Orsulic S, Karlan BY: Can molecular subtyping be used to triage women with advanced ovarian cancer to primary debulking surgery or neoadjuvant chemotherapy? Gynecolo Oncol. 2019 Feb; 152(2):221-222. Doi: 10.1016/j.ygyno.2019.01.005 PMID:30704616
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Karlan BY et al: Shared heritability and functional enrichment across six solid cancers. Nat Commun. 2019 Jan 25; 10(1):431. Doi: 10.1038/s41467-018-08054-4 PMID: 30683880
Hooda J, Novak M, Salomon MP, Matsuba C, Ramos RI, MacDuffie E, Song M, Hirsch MS, Lester J, Parkash V, Karlan BY, Oren M, Hoon DS, Drapkin R.: Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways that Facilitate progression of Ovarian Cancer Cancer Res. 2019 Feb 15;79(4):760-772. doi: 10.1158/0008-5472.CAN-18-2297. Epub 2018 Dec 18. PMID: 30563893
Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Karlan BY et al: Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biromarkers and Epitherlial Ovarian Cancer Risk. Cancer Res. 2019 Feb1; 79(3):505-517. doi: 10.1158/0008-5472.CAN-18-2726. Epub 2018 Dec 17. PMID: 30559148
Andersen MR, Karlan BY, Drescher CW, Paley P, Hawley S, Palomares M, Daly MB, Urban N: False-positive Screening Events and Worry Influence Decisions About Surgery Among High-risk Women. Health Psychol. Doi: 10, 1037/hea0000647; 2018 Nov 15 (Epub ahead of print). PMID: 304312092
Chang H, Rimel BJ, Li AJ, Cass I, Karlan BY, Walsh C: Ultrasound guided transversus abdominis plane (TAP) block utilization in multimodal pain management after open gynecological surgery. Gynecol Oncol Rep. 26:75-77; 2018 Oct 15; eCollection 2018 Nov. PMID: 30364775
Qian F, Wang S, Mitchell J, McGuffog, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Karlan BY et al: Height and body mass index as modifiers of breast cancer risk in BRCA 1/2 mutation carriers: A Mendelian randomization study. J Natl Cancer Inst. 2018 Oct 12 (Epub ahead of print). PMID: 30312457
Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Karlan BY et al: Association of p16 Expression with Prognosis Varies Across Carcinoma Histotypes: An Ovarian Tumor Tissue Analysis Consortium Study. J Pathol Clin Res. 4(4):250-261; 2018 Oct (Epub 2018 Sep 21). PMID: 30062862
Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JMIm HK, Chen YA, Permuth JB, Reid BM Teer JK, Karlan BY et al: A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. 78(18):5419-5430; 2018 Sep 15 (Epub 2018 Jul 27). PMID: 30054336

In The News

2016 "Beverly Hills Tomorrow 2021: A Vision of the Future; An Interview with CNN's Larry King"
2016 CBS Evening News, various print and television media: Report on the State of the Science on Ovarian Cancer Research, national release from the National
Academies of Science, Engineering and Medicine
2014 AirTalk Radio with Larry Mantle – HPV Vaccinations
2013 Interview for Studio 11 – Fox News
2012 Hallmark Channel interview – Home and Family
2011 Vital Options International – Talk Radio
2009 PBS Documentary The Whisper - The Silent Crisis of Ovarian Cancer
2007, 2008, 2009 Satellite Media Tour, Gynecologic Cancer Awareness, Gynecologic Cancer Foundation

Awards

2019 Los Angeles Magazine Top Doctors
2018 Director's Service Award, National Cancer Institute
2018 Fellow of the American Society of Clinical Oncology (FASCO)
2016 Pioneer in Medicine Award, Cedars-Sinai Medical Center
2016 Triumph Award, American Cancer Society
2015 Rosalind Franklin Excellence in Ovarian Cancer Research Award, Ovarian Cancer National Alliance
2015 Claudia Cohen Prize for Outstanding Gynecologic Researcher, Foundation for Women's Cancer
2015 Distinguished Service Award, Society of Gynecologic Oncology
2012 Ten Women Leaders Who Impact LA, Los Angeles Magazine, Game Changers 2
2012 Nominated for the PROSE Award Association of American Publishers
2011 - 2017 Professorship, American Cancer Society
2011 Honoree , American Cancer Society's Southern California Invitational 2011 Harvard Physician Leadership in Academic Medicine Program
2008 Margaret Greenfield/Carmel Cohen M.D. Prize for Excellence in Ovarian Cancer Research Gynecologic Cancer Foundation
2006-2011 Early Detection Professorship
American Cancer Society, California Division

Beth Y. Karlan, MD click here to update your profile

Back to search